EZZ Life Science Holdings Ltd
ASX:EZZ
Cash Flow Statement
Cash Flow Statement
EZZ Life Science Holdings Ltd
| Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
2
|
|
| Cash Taxes Paid |
(1)
|
(1)
|
(0)
|
(1)
|
(1)
|
(1)
|
(2)
|
(4)
|
(3)
|
|
| Cash Interest Paid |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Change in Working Capital |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Operating Activities |
0
N/A
|
(0)
N/A
|
2
N/A
|
1
-51%
|
4
+327%
|
4
+1%
|
6
+52%
|
8
+34%
|
4
-47%
|
|
| Investing Cash Flow | ||||||||||
| Capital Expenditures |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Items |
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
|
| Cash from Investing Activities |
(0)
N/A
|
(0)
+15%
|
(0)
+4%
|
(0)
+42%
|
(0)
-1 239%
|
(0)
-273%
|
(0)
-16%
|
(0)
+4%
|
(1)
-29%
|
|
| Financing Cash Flow | ||||||||||
| Net Issuance of Common Stock |
6
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Cash Paid for Dividends |
0
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
|
| Other |
(0)
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Cash from Financing Activities |
5
N/A
|
5
-3%
|
(0)
N/A
|
(0)
-6%
|
(1)
-160%
|
(1)
-48%
|
(1)
+48%
|
(1)
-77%
|
(2)
-110%
|
|
| Change in Cash | ||||||||||
| Effect of Foreign Exchange Rates |
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Change in Cash |
6
N/A
|
5
-10%
|
2
-69%
|
1
-60%
|
3
+426%
|
3
-10%
|
5
+71%
|
7
+40%
|
2
-75%
|
|
| Free Cash Flow | ||||||||||
| Free Cash Flow |
0
N/A
|
(0)
N/A
|
2
N/A
|
1
-51%
|
4
+320%
|
4
-6%
|
6
+56%
|
8
+38%
|
4
-48%
|
|